| NCT04073368 |
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT04073368 |
Active, not recruiting |
Axcella Health, Inc |
2020-03-31 |
| NCT04378010 |
A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH |
https://ClinicalTrials.gov/show/NCT04378010 |
Recruiting |
Enanta Pharmaceuticals |
2022-11-30 |
| NCT04197479 |
A Phase 3 Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease (NAFLD) Patients |
https://ClinicalTrials.gov/show/NCT04197479 |
Recruiting |
Madrigal Pharmaceuticals, Inc. |
2021-12-31 |
| NCT04166773 |
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT04166773 |
Recruiting |
Eli Lilly and Company |
2022-03-21 |
| NCT03913351 |
Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver |
https://ClinicalTrials.gov/show/NCT03913351 |
Recruiting |
Chinese University of Hong Kong |
2022-04-30 |
| NCT04146805 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04146805 |
Recruiting |
Blade Therapeutics |
2020-10-30 |
| NCT03957070 |
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis |
https://ClinicalTrials.gov/show/NCT03957070 |
Recruiting |
Sonic Incytes |
2020-10-31 |
| NCT03400163 |
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03400163 |
Completed |
Bristol-Myers Squibb |
2017-01-18 |
| NCT03375788 |
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT03375788 |
Recruiting |
Massachusetts General Hospital |
2022-10-31 |
| NCT03375008 |
Predictable MR Index for Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03375008 |
Completed |
Korea University Guro Hospital |
2018-08-07 |
| NCT03374358 |
Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir |
https://ClinicalTrials.gov/show/NCT03374358 |
Completed |
Helsinki University Central Hospital |
2019-11-02 |
| NCT03373643 |
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03373643 |
Recruiting |
University Hospital, Angers |
2019-12-14 |
| NCT03369145 |
High-fat Overfeeding, Hepatokines and Appetite Regulation |
https://ClinicalTrials.gov/show/NCT03369145 |
Completed |
Loughborough University |
2018-07-31 |
| NCT03526445 |
Hepatic Metabolic Changes in Response to Glucagon Infusion |
https://ClinicalTrials.gov/show/NCT03526445 |
Completed |
Steno Diabetes Center Copenhagen |
2019-06-12 |
| NCT03354247 |
Lifestyle Intervention in Fatty Liver (NAFLD) |
https://ClinicalTrials.gov/show/NCT03354247 |
Recruiting |
University of Bari |
2020-06-30 |
| NCT03339245 |
Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study |
https://ClinicalTrials.gov/show/NCT03339245 |
Completed |
Rockefeller University |
2018-10-02 |
| NCT03334214 |
Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03334214 |
Completed |
Ionis Pharmaceuticals, Inc. |
2018-11-28 |
| NCT03332940 |
An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH |
https://ClinicalTrials.gov/show/NCT03332940 |
Completed |
Navidea Biopharmaceuticals |
2019-03-10 |
| NCT03289897 |
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan |
https://ClinicalTrials.gov/show/NCT03289897 |
Recruiting |
Perspectum Diagnostics Ltd |
2020-12-31 |
| NCT03294941 |
The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology |
https://ClinicalTrials.gov/show/NCT03294941 |
Active, not recruiting |
HepQuant, LLC |
2022-05-31 |
| NCT03294850 |
Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery |
https://ClinicalTrials.gov/show/NCT03294850 |
Active, not recruiting |
Translational Research Institute for Metabolism and Diabetes, Florida |
2019-12-20 |
| NCT03260543 |
Efficacy and Safety of Fermented Ginseng Powder on Liver Function |
https://ClinicalTrials.gov/show/NCT03260543 |
Completed |
Chonbuk National University Hospital |
2016-11-30 |
| NCT03256526 |
6-week Safety and PD Study in Adults With NAFLD |
https://ClinicalTrials.gov/show/NCT03256526 |
Completed |
Pfizer |
2018-03-30 |
| NCT03248882 |
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT03248882 |
Completed |
Pfizer |
2019-02-26 |
| NCT03241121 |
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT03241121 |
Active, not recruiting |
University of Lausanne Hospitals |
2020-03-31 |
| NCT03222206 |
The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03222206 |
Completed |
Korea University Guro Hospital |
2019-02-22 |
| NCT03213145 |
Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03213145 |
Completed |
Enanta Pharmaceuticals |
2017-08-10 |
| NCT03205150 |
Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients |
https://ClinicalTrials.gov/show/NCT03205150 |
Completed |
Novartis |
2019-11-11 |
| NCT03203486 |
Response of NAFLD Patients to Mediterranean Diet |
https://ClinicalTrials.gov/show/NCT03203486 |
Completed |
Harokopio University |
2014-07-31 |
| NCT03198572 |
Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03198572 |
Recruiting |
Fudan University |
2020-12-30 |
| NCT03186859 |
Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) |
https://ClinicalTrials.gov/show/NCT03186859 |
Recruiting |
University of Oxford |
2020-08-31 |
| NCT03184376 |
Histological Improvement of NASH With Prebiotic |
https://ClinicalTrials.gov/show/NCT03184376 |
Completed |
University of Calgary |
2015-12-16 |
| NCT03166735 |
Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH |
https://ClinicalTrials.gov/show/NCT03166735 |
Completed |
Boehringer Ingelheim |
2019-06-14 |
| NCT03151798 |
The Liver Health Study for Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT03151798 |
Recruiting |
University of Missouri-Columbia |
2022-04-29 |
| NCT03145350 |
The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and Metabolism |
https://ClinicalTrials.gov/show/NCT03145350 |
Completed |
University of Oxford |
2019-12-31 |
| NCT03143166 |
Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan |
https://ClinicalTrials.gov/show/NCT03143166 |
Completed |
Boehringer Ingelheim |
2017-07-27 |
| NCT03135873 |
Mastiha Treatment for Obese With NAFLD Diagnosis |
https://ClinicalTrials.gov/show/NCT03135873 |
Completed |
Harokopio University |
2019-06-08 |
| NCT03129113 |
Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV |
https://ClinicalTrials.gov/show/NCT03129113 |
Active, not recruiting |
University College, London |
2020-11-30 |
| NCT03082703 |
Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03082703 |
Completed |
University of Alabama at Birmingham |
2016-12-01 |
| NCT03073343 |
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine |
https://ClinicalTrials.gov/show/NCT03073343 |
Recruiting |
Southern California Institute for Research and Education |
2021-12-30 |
| NCT03068078 |
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03068078 |
Recruiting |
Odense University Hospital |
2019-12-31 |
| NCT03068065 |
Antidiabetic Effects on Intrahepatic Fat |
https://ClinicalTrials.gov/show/NCT03068065 |
Completed |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2014-11-30 |
| NCT03067428 |
Effects of Fructose Restriction on Liver Steatosis |
https://ClinicalTrials.gov/show/NCT03067428 |
Completed |
Maastricht University Medical Center |
2019-12-20 |
| NCT03061721 |
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03061721 |
Active, not recruiting |
Zydus Discovery DMCC |
2019-08-22 |
| NCT03060538 |
A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03060538 |
Completed |
Genentech, Inc. |
2019-12-13 |
| NCT03059446 |
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03059446 |
Enrolling by invitation |
Tobira Therapeutics, Inc. |
2029-11-27 |
| NCT03042767 |
Anti-LPS Antibody Treatment for Pediatric NAFLD |
https://ClinicalTrials.gov/show/NCT03042767 |
Completed |
Emory University |
2019-10-23 |
| NCT03008070 |
Phase 2b Study in NASH to Assess IVA337 |
https://ClinicalTrials.gov/show/NCT03008070 |
Completed |
Inventiva Pharma |
2020-02-20 |
| NCT03007329 |
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. |
https://ClinicalTrials.gov/show/NCT03007329 |
Completed |
Medical University of Vienna |
2019-11-26 |
| NCT02974374 |
Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT02974374 |
Completed |
Pfizer |
2017-01-31 |
| NCT02973295 |
Silymarin in NAFLD |
https://ClinicalTrials.gov/show/NCT02973295 |
Recruiting |
University Hospital Rijeka |
2020-12-31 |
| NCT02970942 |
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. |
https://ClinicalTrials.gov/show/NCT02970942 |
Completed |
Novo Nordisk A/S |
2020-02-13 |
| NCT02962297 |
Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02962297 |
Active, not recruiting |
Zhejiang Medicine Co., Ltd. |
2021-01-31 |
| NCT02960204 |
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02960204 |
Completed |
Conatus Pharmaceuticals Inc. |
2018-10-02 |
| NCT02941549 |
Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT02941549 |
Completed |
Afimmune |
2018-12-05 |
| NCT02929901 |
The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02929901 |
Completed |
National Nutrition and Food Technology Institute |
2018-09-30 |
| NCT02927314 |
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02927314 |
Completed |
Can-Fite BioPharma |
2020-03-01 |
| NCT02927184 |
Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02927184 |
Completed |
Viking Therapeutics, Inc. |
2019-03-26 |
| NCT02923804 |
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients |
https://ClinicalTrials.gov/show/NCT02923804 |
Completed |
Pronova BioPharma |
2017-12-01 |
| NCT02923154 |
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) |
https://ClinicalTrials.gov/show/NCT02923154 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2018-03-31 |
| NCT02891408 |
Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function |
https://ClinicalTrials.gov/show/NCT02891408 |
Completed |
Gilead Sciences |
2019-05-05 |
| NCT02880189 |
EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity |
https://ClinicalTrials.gov/show/NCT02880189 |
Completed |
Mayo Clinic |
2018-03-13 |
| NCT02875821 |
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone |
https://ClinicalTrials.gov/show/NCT02875821 |
Completed |
Yonsei University |
2017-06-07 |
| NCT02856555 |
GS-0976 in Adults With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02856555 |
Completed |
Gilead Sciences |
2017-07-18 |
| NCT02855164 |
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02855164 |
Completed |
Novartis |
2020-04-06 |
| NCT02854605 |
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02854605 |
Completed |
Gilead Sciences |
2018-01-09 |
| NCT02820285 |
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH |
https://ClinicalTrials.gov/show/NCT02820285 |
Completed |
Centre Hospitalier Universitaire de Nice |
2016-09-30 |
| NCT02826525 |
AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. |
https://ClinicalTrials.gov/show/NCT02826525 |
Completed |
AstraZeneca |
2019-10-11 |
| NCT02808312 |
Pharmacokinetics and Pharmacodynamics of GS-9674 in Adults With Normal and Impaired Hepatic Function |
https://ClinicalTrials.gov/show/NCT02808312 |
Completed |
Gilead Sciences |
2018-10-16 |
| NCT02798861 |
Controlled Attenuation Parameter (CAP) in Liver Allografts |
https://ClinicalTrials.gov/show/NCT02798861 |
Completed |
University of Pittsburgh |
2019-06-01 |
| NCT02784925 |
Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement |
https://ClinicalTrials.gov/show/NCT02784925 |
Completed |
Taipei Medical University WanFang Hospital |
2016-07-31 |
| NCT02784444 |
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC 0602K in Patients With NASH |
https://ClinicalTrials.gov/show/NCT02784444 |
Completed |
Cirius Therapeutics, Inc. |
2019-06-30 |
| NCT02726542 |
Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents |
https://ClinicalTrials.gov/show/NCT02726542 |
Active, not recruiting |
Massachusetts General Hospital |
2020-03-31 |
| NCT02704403 |
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02704403 |
Recruiting |
Genfit |
2021-12-31 |
| NCT02696941 |
SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis |
https://ClinicalTrials.gov/show/NCT02696941 |
Completed |
University of Oxford |
2018-04-01 |
| NCT02690792 |
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02690792 |
Completed |
University of Texas Southwestern Medical Center |
2016-12-31 |
| NCT02686762 |
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis |
https://ClinicalTrials.gov/show/NCT02686762 |
Completed |
Conatus Pharmaceuticals Inc. |
2019-01-29 |
| NCT02686476 |
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02686476 |
Completed |
Medanta, The Medicity, India |
2017-09-30 |
| NCT02684591 |
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02684591 |
Completed |
University of California, San Diego |
2018-02-28 |
| NCT02682173 |
Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver |
https://ClinicalTrials.gov/show/NCT02682173 |
Completed |
University Hospital, Basel, Switzerland |
2017-07-31 |
| NCT02679417 |
The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02679417 |
Completed |
Mahidol University |
2016-09-30 |
| NCT02670590 |
NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life |
https://ClinicalTrials.gov/show/NCT02670590 |
Completed |
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele |
2014-12-31 |
| NCT02654977 |
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02654977 |
Active, not recruiting |
University of Michigan |
2020-02-29 |
| NCT02654002 |
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics |
https://ClinicalTrials.gov/show/NCT02654002 |
Completed |
Gilead Sciences |
2016-07-31 |
| NCT02653300 |
A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02653300 |
Recruiting |
Oramed, Ltd. |
2020-03-31 |
| NCT02649465 |
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD |
https://ClinicalTrials.gov/show/NCT02649465 |
Recruiting |
Kanazawa University |
2020-09-30 |
| NCT02644239 |
Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy |
https://ClinicalTrials.gov/show/NCT02644239 |
Recruiting |
University of Sao Paulo |
2020-07-31 |
| NCT02642172 |
Prebiotics in Patients With Non-alcoholic Liver Disease |
https://ClinicalTrials.gov/show/NCT02642172 |
Recruiting |
Kaplan Medical Center |
2025-01-31 |
| NCT02637973 |
Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02637973 |
Completed |
German Diabetes Center |
2018-08-31 |
| NCT02633956 |
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) |
https://ClinicalTrials.gov/show/NCT02633956 |
Completed |
Intercept Pharmaceuticals |
2017-03-21 |
| NCT02612662 |
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT02612662 |
Active, not recruiting |
AstraZeneca |
2017-11-04 |
| NCT02605616 |
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT02605616 |
Active, not recruiting |
University of Virginia |
2019-12-31 |
| NCT02599038 |
Serine Supplementation for Obese Subjects With Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02599038 |
Completed |
Sahlgrenska University Hospital, Sweden |
2016-10-31 |
| NCT00862433 |
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women |
https://ClinicalTrials.gov/show/NCT00862433 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-12-31 |
| NCT04365868 |
Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis |
https://ClinicalTrials.gov/show/NCT04365868 |
Recruiting |
Galectin Therapeutics Inc. |
2023-06-30 |
| NCT02571192 |
A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose |
https://ClinicalTrials.gov/show/NCT02571192 |
Completed |
Mirum Pharmaceuticals, Inc. |
2015-10-01 |
| NCT02568787 |
The Effect of an RBAC Supplement (BRM4) on NAFLD |
https://ClinicalTrials.gov/show/NCT02568787 |
Completed |
University of Miami |
2017-06-10 |
| NCT02568605 |
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02568605 |
Active, not recruiting |
University of Calgary |
2019-08-31 |
| NCT02565446 |
Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram |
https://ClinicalTrials.gov/show/NCT02565446 |
Recruiting |
Mayo Clinic |
2022-01-31 |
| NCT03701828 |
Liver Health and Metabolic Function in People With Obesity |
https://ClinicalTrials.gov/show/NCT03701828 |
Recruiting |
Washington University School of Medicine |
2023-11-01 |
| NCT02558530 |
Resolution of Liver Fat in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02558530 |
Active, not recruiting |
Helsinki University Central Hospital |
2025-11-30 |
| NCT03392779 |
Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics |
https://ClinicalTrials.gov/show/NCT03392779 |
Completed |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2018-12-21 |
| NCT02548351 |
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment |
https://ClinicalTrials.gov/show/NCT02548351 |
Active, not recruiting |
Intercept Pharmaceuticals |
2022-10-31 |
| NCT02546609 |
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02546609 |
Completed |
NuSirt Biopharma |
2016-11-30 |
| NCT02535195 |
Effect of Ginger Supplement on Non-alcoholic Fatty Liver |
https://ClinicalTrials.gov/show/NCT02535195 |
Completed |
National Nutrition and Food Technology Institute |
2014-02-28 |
| NCT02528305 |
The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02528305 |
Completed |
University of Bath |
2016-06-30 |
| NCT02526732 |
Hepatic Inflammation and Physical Performance in Patients With NASH |
https://ClinicalTrials.gov/show/NCT02526732 |
Completed |
Johannes Gutenberg University Mainz |
2017-12-20 |
| NCT02513121 |
Dietary Treatment Study of Pediatric NAFLD |
https://ClinicalTrials.gov/show/NCT02513121 |
Completed |
University of California, San Diego |
2017-08-31 |
| NCT02510599 |
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis |
https://ClinicalTrials.gov/show/NCT02510599 |
Completed |
Melinta Therapeutics, Inc. |
2017-01-27 |
| NCT02491905 |
Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients |
https://ClinicalTrials.gov/show/NCT02491905 |
Completed |
Huons Co., Ltd. |
2015-05-31 |
| NCT02491229 |
“Hepafast” in Non-alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT02491229 |
Completed |
University of Hohenheim |
2015-05-31 |
| NCT02466516 |
Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 |
https://ClinicalTrials.gov/show/NCT02466516 |
Completed |
Gilead Sciences |
2016-10-11 |
| NCT02461212 |
Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth |
https://ClinicalTrials.gov/show/NCT02461212 |
Completed |
Emory University |
2017-03-17 |
| NCT02443116 |
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02443116 |
Active, not recruiting |
NGM Biopharmaceuticals, Inc |
2019-09-30 |
| NCT02442687 |
JKB-121 for the Treatment of Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02442687 |
Completed |
Duke University |
2017-09-24 |
| NCT02427087 |
Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity |
https://ClinicalTrials.gov/show/NCT02427087 |
Completed |
University of Sao Paulo General Hospital |
2014-12-31 |
| NCT02421094 |
Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis |
https://ClinicalTrials.gov/show/NCT02421094 |
Completed |
Galectin Therapeutics Inc. |
2016-09-27 |
| NCT02413372 |
A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02413372 |
Completed |
Bristol-Myers Squibb |
2017-01-18 |
| NCT02412540 |
Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH |
https://ClinicalTrials.gov/show/NCT02412540 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-06-30 |
| NCT02395900 |
The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02395900 |
Completed |
National Nutrition and Food Technology Institute |
2014-08-31 |
| NCT02394353 |
Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass |
https://ClinicalTrials.gov/show/NCT02394353 |
Completed |
Ministry of Health, Brazil |
2015-05-31 |
| NCT02383485 |
Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children |
https://ClinicalTrials.gov/show/NCT02383485 |
Completed |
Augusta University |
2013-05-31 |
| NCT02378259 |
Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity |
https://ClinicalTrials.gov/show/NCT02378259 |
Active, not recruiting |
Göteborg University |
2021-06-30 |
| NCT02369536 |
Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT02369536 |
Completed |
Neuromed IRCCS |
2016-09-15 |
| NCT02366052 |
Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study |
https://ClinicalTrials.gov/show/NCT02366052 |
Completed |
Johannes Gutenberg University Mainz |
2017-05-10 |
| NCT02358928 |
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT02358928 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2017-03-31 |
| NCT02354976 |
A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. |
https://ClinicalTrials.gov/show/NCT02354976 |
Completed |
AstraZeneca |
2016-05-26 |
| NCT02347007 |
Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults |
https://ClinicalTrials.gov/show/NCT02347007 |
Completed |
Columbia University |
2016-06-30 |
| NCT02337660 |
Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia |
https://ClinicalTrials.gov/show/NCT02337660 |
Completed |
University Hospital, Gentofte, Copenhagen |
2016-01-31 |
| NCT02330549 |
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD |
https://ClinicalTrials.gov/show/NCT02330549 |
Completed |
Tobira Therapeutics, Inc. |
2016-08-11 |
| NCT02329405 |
The Effects of PXR Activation on Hepatic Fat Content |
https://ClinicalTrials.gov/show/NCT02329405 |
Completed |
University of Oulu |
2017-01-31 |
| NCT02316717 |
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02316717 |
Completed |
Immuron Ltd. |
2017-10-30 |
| NCT02314026 |
BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH |
https://ClinicalTrials.gov/show/NCT02314026 |
Completed |
Exalenz Bioscience LTD. |
2017-06-30 |
| NCT02303730 |
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02303730 |
Completed |
Fudan University |
2017-11-30 |
| NCT02303314 |
Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02303314 |
Completed |
Shiraz University of Medical Sciences |
2017-08-31 |
| NCT02290106 |
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat |
https://ClinicalTrials.gov/show/NCT02290106 |
Completed |
Massachusetts General Hospital |
2018-04-30 |
| NCT02289235 |
Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM |
https://ClinicalTrials.gov/show/NCT02289235 |
Enrolling by invitation |
Shiraz University of Medical Sciences |
2019-11-01 |
| NCT02287779 |
Safety and Tolerability Study of SHP626 in Overweight and Obese Adults |
https://ClinicalTrials.gov/show/NCT02287779 |
Completed |
Mirum Pharmaceuticals, Inc. |
2015-06-19 |
| NCT02285205 |
A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD |
https://ClinicalTrials.gov/show/NCT02285205 |
Completed |
Yonsei University |
2015-11-30 |
| NCT02279524 |
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH |
https://ClinicalTrials.gov/show/NCT02279524 |
Completed |
Galmed Pharmaceuticals Ltd |
2018-05-22 |
| NCT02279407 |
A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT02279407 |
Completed |
AstraZeneca |
2015-12-31 |
| NCT02258126 |
Effect of Exercise on Hepatic Fat in Overweight Children |
https://ClinicalTrials.gov/show/NCT02258126 |
Completed |
Basque Country University |
2017-11-30 |
| NCT02242149 |
Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects |
https://ClinicalTrials.gov/show/NCT02242149 |
Completed |
Universidade Federal do Rio de Janeiro |
2017-01-31 |
| NCT04452409 |
Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy |
https://ClinicalTrials.gov/show/NCT04452409 |
Recruiting |
Cairo University |
2020-10-01 |
| NCT02235233 |
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin |
https://ClinicalTrials.gov/show/NCT02235233 |
Completed |
University of North Carolina, Chapel Hill |
2016-07-31 |
| NCT02231333 |
The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis |
https://ClinicalTrials.gov/show/NCT02231333 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-07-31 |
| NCT02217475 |
Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT02217475 |
Completed |
Tobira Therapeutics, Inc. |
2016-06-30 |
| NCT02217345 |
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02217345 |
Recruiting |
Massachusetts General Hospital |
2021-01-31 |
| NCT02216552 |
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents |
https://ClinicalTrials.gov/show/NCT02216552 |
Completed |
University of Manitoba |
2017-01-01 |
| NCT02196831 |
Tesamorelin Effects on Liver Fat and Histology in HIV |
https://ClinicalTrials.gov/show/NCT02196831 |
Completed |
Massachusetts General Hospital |
2019-01-16 |
| NCT02147925 |
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects |
https://ClinicalTrials.gov/show/NCT02147925 |
Completed |
Sun Yat-sen University |
2017-04-30 |
| NCT02132442 |
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes |
https://ClinicalTrials.gov/show/NCT02132442 |
Completed |
University of Massachusetts, Worcester |
2016-10-31 |
| NCT02117700 |
Fatty Liver Disease in Obese Children |
https://ClinicalTrials.gov/show/NCT02117700 |
Active, not recruiting |
Nemours Children’s Clinic |
2018-04-30 |
| NCT02116192 |
Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents |
https://ClinicalTrials.gov/show/NCT02116192 |
Completed |
University of Wisconsin, Madison |
2016-07-31 |
| NCT02102646 |
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism |
https://ClinicalTrials.gov/show/NCT02102646 |
Completed |
Herlev Hospital |
2015-10-31 |
| NCT02098317 |
DHA and Vitamin D in Children With Biopsy-proven NAFLD |
https://ClinicalTrials.gov/show/NCT02098317 |
Completed |
Bambino Gesù Hospital and Research Institute |
2015-05-31 |
| NCT02077374 |
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases |
https://ClinicalTrials.gov/show/NCT02077374 |
Completed |
Conatus Pharmaceuticals Inc. |
2015-03-31 |
| NCT02075164 |
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD |
https://ClinicalTrials.gov/show/NCT02075164 |
Recruiting |
Medical University of Vienna |
2019-06-30 |
| NCT02068339 |
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02068339 |
Completed |
PharmaKing |
2016-02-29 |
| NCT01317576 |
Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver! |
https://ClinicalTrials.gov/show/NCT01317576 |
Completed |
Maastricht University Medical Center |
2015-11-30 |
| NCT01285362 |
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study |
https://ClinicalTrials.gov/show/NCT01285362 |
Completed |
Columbia University |
2014-09-30 |
| NCT01284634 |
Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01284634 |
Completed |
GW Research Ltd |
2012-07-13 |
| NCT01278056 |
The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01278056 |
Completed |
Crolll Gmbh |
2012-03-31 |
| NCT01277237 |
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01277237 |
Completed |
University of Edinburgh |
2012-08-31 |
| NCT01277094 |
A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01277094 |
Completed |
Hoffmann-La Roche |
2012-03-31 |
| NCT02030977 |
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT02030977 |
Completed |
National Nutrition and Food Technology Institute |
2013-02-28 |
| NCT02019056 |
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis |
https://ClinicalTrials.gov/show/NCT02019056 |
Completed |
PharmaKing |
2014-12-31 |
| NCT02018237 |
High Fructose Corn Syrup |
https://ClinicalTrials.gov/show/NCT02018237 |
Completed |
Washington University School of Medicine |
2016-03-31 |
| NCT04173065 |
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH |
https://ClinicalTrials.gov/show/NCT04173065 |
Recruiting |
Viking Therapeutics, Inc. |
2021-03-31 |
| NCT04152473 |
Safety and Tolerability of Oral Proglumide for NASH |
https://ClinicalTrials.gov/show/NCT04152473 |
Recruiting |
Georgetown University |
2021-07-31 |
| NCT04065841 |
Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. |
https://ClinicalTrials.gov/show/NCT04065841 |
Recruiting |
Novartis |
2022-03-15 |
| NCT03357380 |
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver |
https://ClinicalTrials.gov/show/NCT03357380 |
Completed |
Novo Nordisk A/S |
2020-03-20 |
| NCT02006498 |
Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT02006498 |
Completed |
University of Malaya |
2015-12-31 |
| NCT01999101 |
Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients |
https://ClinicalTrials.gov/show/NCT01999101 |
Completed |
Phenex Pharmaceuticals AG |
2015-01-31 |
| NCT01992809 |
Omega 3 Supplementation in Fatty Liver |
https://ClinicalTrials.gov/show/NCT01992809 |
Completed |
University of Sao Paulo General Hospital |
2011-06-30 |
| NCT01985009 |
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. |
https://ClinicalTrials.gov/show/NCT01985009 |
Completed |
Echosens |
2017-01-17 |
| NCT01975935 |
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT01975935 |
Completed |
University of Michigan |
2016-04-25 |
| NCT01963845 |
Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01963845 |
Completed |
University of California, San Diego |
2016-01-31 |
| NCT04450875 |
Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD |
https://ClinicalTrials.gov/show/NCT04450875 |
Completed |
Universidad Veracruzana |
2016-02-01 |
| NCT01940263 |
Purified Anthocyanin and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01940263 |
Completed |
Shaoguan University |
2014-01-31 |
| NCT01934777 |
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01934777 |
Completed |
Bambino Gesù Hospital and Research Institute |
2014-10-31 |
| NCT01930123 |
Impact of Fructose on Metabolism, Energy Homeostasis and MR Biomarkers in NAFLD |
https://ClinicalTrials.gov/show/NCT01930123 |
Recruiting |
Duke University |
2020-08-31 |
| NCT01919294 |
Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) |
https://ClinicalTrials.gov/show/NCT01919294 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2017-01-30 |
| NCT01900015 |
Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection |
https://ClinicalTrials.gov/show/NCT01900015 |
Completed |
Andaluz Health Service |
2017-01-17 |
| NCT01899859 |
Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis |
https://ClinicalTrials.gov/show/NCT01899859 |
Completed |
Galectin Therapeutics Inc. |
2015-02-28 |
| NCT01894438 |
Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01894438 |
Completed |
Harokopio University |
2017-05-31 |
| NCT01876108 |
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01876108 |
Completed |
Tehran University of Medical Sciences |
2013-07-31 |
| NCT01875978 |
Effect of Phytosterols on Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01875978 |
Completed |
China Medical University Hospital |
2012-12-31 |
| NCT01874249 |
Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01874249 |
Completed |
Fundación ClÃnica Médica Sur |
2015-08-31 |
| NCT01842282 |
Amlexanox for Type 2 Diabetes and Obesity |
https://ClinicalTrials.gov/show/NCT01842282 |
Active, not recruiting |
University of Michigan |
2020-12-31 |
| NCT01817491 |
Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol |
https://ClinicalTrials.gov/show/NCT01817491 |
Completed |
The Cleveland Clinic |
2014-05-31 |
| NCT01811472 |
Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients |
https://ClinicalTrials.gov/show/NCT01811472 |
Completed |
Novartis |
2014-09-30 |
| NCT01798719 |
Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01798719 |
Completed |
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis |
2011-10-31 |
| NCT01792115 |
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E |
https://ClinicalTrials.gov/show/NCT01792115 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-08-30 |
| NCT01791959 |
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01791959 |
Completed |
National Nutrition and Food Technology Institute |
2012-10-31 |
| NCT01790984 |
How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? |
https://ClinicalTrials.gov/show/NCT01790984 |
Completed |
University of Surrey |
2011-08-31 |
| NCT01787591 |
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT01787591 |
Completed |
Ohio State University |
2015-01-31 |
| NCT01766960 |
Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease |
https://ClinicalTrials.gov/show/NCT01766960 |
Completed |
University of North Carolina, Chapel Hill |
2014-03-31 |
| NCT01761370 |
Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT01761370 |
Completed |
National University Hospital, Singapore |
2008-09-30 |
| NCT01761318 |
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients |
https://ClinicalTrials.gov/show/NCT01761318 |
Completed |
Leiden University Medical Center |
2016-03-31 |
| NCT01759628 |
Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01759628 |
Completed |
Tehran University of Medical Sciences |
2013-06-30 |
| NCT01754714 |
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group |
https://ClinicalTrials.gov/show/NCT01754714 |
Completed |
Abbott |
2014-09-30 |
| NCT01750021 |
Effects of Fat and Carbohydrates in Obese Men |
https://ClinicalTrials.gov/show/NCT01750021 |
Completed |
Haukeland University Hospital |
2014-01-31 |
| NCT01747772 |
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01747772 |
Completed |
Massachusetts General Hospital |
2014-02-14 |
| NCT03350165 |
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT03350165 |
Active, not recruiting |
Kowa Company, Ltd. |
2019-04-03 |
| NCT01712711 |
Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01712711 |
Completed |
Tehran University of Medical Sciences |
2013-02-28 |
| NCT01707914 |
Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01707914 |
Completed |
Shaoguan University |
2012-10-31 |
| NCT01696487 |
Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. |
https://ClinicalTrials.gov/show/NCT01696487 |
Completed |
Medical University of Vienna |
2013-02-28 |
| NCT01694849 |
Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT01694849 |
Completed |
Genfit |
2015-02-28 |
| NCT01679197 |
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT01679197 |
Completed |
University of Michigan |
2016-07-13 |
| NCT01680640 |
Investigation of Synbiotic Treatment in NAFLD |
https://ClinicalTrials.gov/show/NCT01680640 |
Recruiting |
University Hospital Southampton NHS Foundation Trust |
2019-10-31 |
| NCT01677325 |
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine |
https://ClinicalTrials.gov/show/NCT01677325 |
Completed |
Fudan University |
2007-01-31 |
| NCT01650181 |
Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01650181 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2014-03-31 |
| NCT01645852 |
A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection |
https://ClinicalTrials.gov/show/NCT01645852 |
Completed |
Dartmouth-Hitchcock Medical Center |
2016-12-31 |
| NCT04328077 |
LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT04328077 |
Recruiting |
Terns, Inc. |
2021-05-31 |
| NCT01579162 |
Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation |
https://ClinicalTrials.gov/show/NCT01579162 |
Active, not recruiting |
HepQuant, LLC |
2020-11-30 |
| NCT01571063 |
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D |
https://ClinicalTrials.gov/show/NCT01571063 |
Completed |
University of Zurich |
2016-05-31 |
| NCT01556113 |
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01556113 |
Completed |
Yale University |
2017-02-28 |
| NCT04321031 |
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) |
https://ClinicalTrials.gov/show/NCT04321031 |
Recruiting |
Pfizer |
2022-11-01 |
| NCT01553500 |
Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01553500 |
Completed |
Bambino Gesù Hospital and Research Institute |
2013-06-30 |
| NCT01548079 |
Ursodeoxycholic Acid in Bariatric Surgery |
https://ClinicalTrials.gov/show/NCT01548079 |
Completed |
Sahlgrenska University Hospital, Sweden |
2009-11-30 |
| NCT01547910 |
Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children |
https://ClinicalTrials.gov/show/NCT01547910 |
Completed |
Children’s Memorial Health Institute, Poland |
2012-03-31 |
| NCT01529268 |
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children |
https://ClinicalTrials.gov/show/NCT01529268 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2015-03-31 |
| NCT01482065 |
The Sleep, Liver Evaluation and Effective Pressure Study |
https://ClinicalTrials.gov/show/NCT01482065 |
Completed |
Johns Hopkins University |
2015-07-31 |
| NCT01464801 |
Resveratrol in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01464801 |
Completed |
University of Aarhus |
2015-02-28 |
| NCT01446276 |
Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01446276 |
Completed |
University of Aarhus |
2014-04-30 |
| NCT01431521 |
Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) |
https://ClinicalTrials.gov/show/NCT01431521 |
Completed |
Merck Sharp & Dohme Corp. |
2012-09-18 |
| NCT01418027 |
Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT01418027 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2013-12-31 |
| NCT01373554 |
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01373554 |
Completed |
PharmaKing |
2013-06-30 |
| NCT01358409 |
Regression of Myocardial Steatosis by Nebivolol |
https://ClinicalTrials.gov/show/NCT01358409 |
Completed |
Cedars-Sinai Medical Center |
2013-02-11 |
| NCT01354626 |
Dietary Protein and Hepatic Fat Accumulation |
https://ClinicalTrials.gov/show/NCT01354626 |
Completed |
Wageningen University |
2012-03-31 |
| NCT01327443 |
Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01327443 |
Completed |
University of Missouri-Columbia |
2012-09-30 |
| NCT04442620 |
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity |
https://ClinicalTrials.gov/show/NCT04442620 |
Active, not recruiting |
University of the Balearic Islands |
2019-11-29 |
| NCT04411862 |
Efficacy of Phosphatidylcholine in NAFLD |
https://ClinicalTrials.gov/show/NCT04411862 |
Completed |
Ain Shams University |
2019-01-03 |
| NCT04400864 |
Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04400864 |
Recruiting |
Rabin Medical Center |
2021-05-01 |
| NCT04389775 |
To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants |
https://ClinicalTrials.gov/show/NCT04389775 |
Recruiting |
Sciwind Biosciences APAC CO Pty. Ltd. |
2020-12-31 |
| NCT04383951 |
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis |
https://ClinicalTrials.gov/show/NCT04383951 |
Recruiting |
Indiana University |
2024-12-31 |
| NCT04364360 |
Sulforaphane Supplementation Study |
https://ClinicalTrials.gov/show/NCT04364360 |
Recruiting |
University of Oxford |
2023-08-31 |
| NCT04355910 |
Intermittent Fasting in Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04355910 |
Recruiting |
Shaoguan University |
2020-04-30 |
| NCT04342793 |
A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH |
https://ClinicalTrials.gov/show/NCT04342793 |
Recruiting |
AngioLab, Inc. |
2020-12-04 |
| NCT04330326 |
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04330326 |
Recruiting |
ScandiBio Therapeutics AB |
2020-09-30 |
| NCT04315350 |
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance |
https://ClinicalTrials.gov/show/NCT04315350 |
Recruiting |
University Hospital, Gentofte, Copenhagen |
2020-12-01 |
| NCT04298736 |
Bariatric Surgery vs. Lifestyle Modification for NASH |
https://ClinicalTrials.gov/show/NCT04298736 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2022-03-20 |
| NCT04282005 |
Metabolic Surgery for Steato-Hepatitis |
https://ClinicalTrials.gov/show/NCT04282005 |
Recruiting |
King’s College London |
2021-03-30 |
| NCT04281121 |
Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver |
https://ClinicalTrials.gov/show/NCT04281121 |
Completed |
Ain Shams University |
2020-01-25 |
| NCT04241575 |
Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages |
https://ClinicalTrials.gov/show/NCT04241575 |
Recruiting |
Chinese University of Hong Kong |
2023-04-30 |
| NCT04235205 |
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04235205 |
Recruiting |
Yokohama City University |
2021-04-30 |
| NCT04230655 |
Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon |
https://ClinicalTrials.gov/show/NCT04230655 |
Recruiting |
Region Örebro County |
2022-12-31 |
| NCT04202354 |
Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH |
https://ClinicalTrials.gov/show/NCT04202354 |
Recruiting |
Arrowhead Pharmaceuticals |
2021-11-30 |
| NCT04194242 |
The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04194242 |
Recruiting |
Sunshine Lake Pharma Co., Ltd. |
2020-07-30 |
| NCT04186793 |
Comparison of Dietary Sugar Reduction Methods |
https://ClinicalTrials.gov/show/NCT04186793 |
Recruiting |
Emory University |
2020-11-30 |
| NCT04180631 |
Quantitative US for Hepatic Steatosis |
https://ClinicalTrials.gov/show/NCT04180631 |
Completed |
Seoul National University Hospital |
2020-01-19 |
| NCT03371355 |
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03371355 |
Completed |
Akcea Therapeutics |
2019-11-21 |
| NCT04161703 |
Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04161703 |
Completed |
Cairo University |
2020-02-20 |
| NCT04142749 |
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04142749 |
Recruiting |
PharmaKing |
2020-10-31 |
| NCT04140123 |
Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT04140123 |
Recruiting |
Guangdong Raynovent Biotech Co., Ltd |
2020-12-31 |
| NCT04137055 |
Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics |
https://ClinicalTrials.gov/show/NCT04137055 |
Recruiting |
Guangdong Raynovent Biotech Co., Ltd |
2020-10-31 |
| NCT04134091 |
A Study to Assess the Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT04134091 |
Recruiting |
Lipocine Inc. |
2020-06-30 |
| NCT04117802 |
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT04117802 |
Recruiting |
Laval University |
2021-01-29 |
| NCT04109742 |
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04109742 |
Recruiting |
Columbia University |
2020-09-30 |
| NCT04104321 |
A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR) |
https://ClinicalTrials.gov/show/NCT04104321 |
Recruiting |
Galmed Pharmaceuticals Ltd |
2022-06-30 |
| NCT04098484 |
Biological Adaptations of Strength Training. |
https://ClinicalTrials.gov/show/NCT04098484 |
Recruiting |
Democritus University of Thrace |
2020-12-25 |
| NCT04074889 |
The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver |
https://ClinicalTrials.gov/show/NCT04074889 |
Recruiting |
Universiti Kebangsaan Malaysia Medical Centre |
2020-07-31 |
| NCT04073407 |
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT04073407 |
Recruiting |
Axcella Health, Inc |
2020-08-31 |
| NCT04066400 |
Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT04066400 |
Recruiting |
Johannes Gutenberg University Mainz |
2020-09-01 |
| NCT04063826 |
PET-MR Study of Fatty Liver |
https://ClinicalTrials.gov/show/NCT04063826 |
Recruiting |
Imperial College London |
2020-01-31 |
| NCT04054297 |
Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat |
https://ClinicalTrials.gov/show/NCT04054297 |
Recruiting |
Maastricht University Medical Center |
2020-08-31 |
| NCT04048135 |
A Multiple Ascending Dose Study of BIO89-100 in Subjects With Biopsy Confirmed NASH or NAFLD and at High Risk of NASH |
https://ClinicalTrials.gov/show/NCT04048135 |
Active, not recruiting |
89bio Ltd. |
2020-06-30 |
| NCT04052516 |
A Phase 2b Study of Icosabutate in Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04052516 |
Recruiting |
NorthSea Therapeutics B.V. |
2021-07-05 |
| NCT04049396 |
Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT04049396 |
Completed |
Islamic Azad University, Tehran |
2019-03-25 |
| NCT04048876 |
Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT04048876 |
Recruiting |
Celgene |
2022-07-06 |
| NCT04046718 |
Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients |
https://ClinicalTrials.gov/show/NCT04046718 |
Completed |
Cairo University |
2019-05-05 |
| NCT04042142 |
Glucagon Resistance in Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT04042142 |
Recruiting |
University of Aarhus |
2021-06-30 |
| NCT04038853 |
Vitamin D in Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04038853 |
Completed |
University Hospital Rijeka |
2017-02-01 |
| NCT04019561 |
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. |
https://ClinicalTrials.gov/show/NCT04019561 |
Recruiting |
MedImmune LLC |
2021-03-31 |
| NCT04012021 |
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI |
https://ClinicalTrials.gov/show/NCT04012021 |
Recruiting |
University of Pisa |
2020-01-31 |
| NCT04004403 |
Alternate Day Fasting Combined and NAFLD for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT04004403 |
Enrolling by invitation |
University of Illinois at Chicago |
2023-09-01 |
| NCT04004325 |
A Study of FT 4101 in Overweight/Obese Participants With NASH |
https://ClinicalTrials.gov/show/NCT04004325 |
Recruiting |
Forma Therapeutics, Inc. |
2020-01-10 |
| NCT04004273 |
Diabetes, Exercise and Liver Fat (DELIVER) |
https://ClinicalTrials.gov/show/NCT04004273 |
Recruiting |
Loughborough University |
2020-04-01 |
| NCT03997422 |
Hepatic Energy Fluxes in NASH and NAS Patients |
https://ClinicalTrials.gov/show/NCT03997422 |
Recruiting |
University of Minnesota |
2021-06-30 |
| NCT03988725 |
Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E |
https://ClinicalTrials.gov/show/NCT03988725 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2019-03-11 |
| NCT03987451 |
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage |
https://ClinicalTrials.gov/show/NCT03987451 |
Active, not recruiting |
Novo Nordisk A/S |
2021-01-06 |
| NCT03987074 |
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03987074 |
Active, not recruiting |
Gilead Sciences |
2020-05-31 |
| NCT03985020 |
Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis |
https://ClinicalTrials.gov/show/NCT03985020 |
Recruiting |
Children’s Hospital Los Angeles |
2020-09-08 |
| NCT03978247 |
Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy |
https://ClinicalTrials.gov/show/NCT03978247 |
Recruiting |
Diafir |
2020-03-31 |
| NCT03976687 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients |
https://ClinicalTrials.gov/show/NCT03976687 |
Recruiting |
Enyo Pharma |
2019-10-25 |
| NCT03976401 |
A Study of AKR-001 in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03976401 |
Recruiting |
Akero Therapeutics, Inc |
2020-03-07 |
| NCT03972319 |
Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study |
https://ClinicalTrials.gov/show/NCT03972319 |
Recruiting |
Khoo Teck Puat Hospital |
2020-07-31 |
| NCT03963921 |
Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients |
https://ClinicalTrials.gov/show/NCT03963921 |
Recruiting |
Promethera Biosciences |
2020-02-29 |
| NCT03819283 |
NASH and Coronary Disease |
https://ClinicalTrials.gov/show/NCT03819283 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-08-15 |
| NCT03953456 |
Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL) |
https://ClinicalTrials.gov/show/NCT03953456 |
Recruiting |
Genfit |
2020-05-31 |
| NCT03942822 |
Chia Supplementation and Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03942822 |
Completed |
Instituto Nacional de Cardiologia Ignacio Chavez |
2017-09-01 |
| NCT03938246 |
Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03938246 |
Recruiting |
Sagimet Biosciences Inc. |
2020-11-30 |
| NCT03936803 |
Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03936803 |
Completed |
Cairo University |
2018-12-05 |
| NCT03912532 |
Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) |
https://ClinicalTrials.gov/show/NCT03912532 |
Recruiting |
NGM Biopharmaceuticals, Inc |
2020-09-30 |
| NCT03912272 |
12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat |
https://ClinicalTrials.gov/show/NCT03912272 |
Recruiting |
The University of Hong Kong |
2023-01-01 |
| NCT03910361 |
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases |
https://ClinicalTrials.gov/show/NCT03910361 |
Enrolling by invitation |
Dong-A ST Co., Ltd. |
2020-09-30 |
| NCT03900429 |
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis |
https://ClinicalTrials.gov/show/NCT03900429 |
Recruiting |
Madrigal Pharmaceuticals, Inc. |
2021-06-30 |
| NCT03897218 |
Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - “A Diet for Liver Health” |
https://ClinicalTrials.gov/show/NCT03897218 |
Recruiting |
RWTH Aachen University |
2020-10-01 |
| NCT03884075 |
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) |
https://ClinicalTrials.gov/show/NCT03884075 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-01-31 |
| NCT03883607 |
Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03883607 |
Recruiting |
Genfit |
2020-11-30 |
| NCT03875625 |
Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention |
https://ClinicalTrials.gov/show/NCT03875625 |
Recruiting |
Chinese University of Hong Kong |
2022-01-12 |
| NCT03867487 |
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03867487 |
Enrolling by invitation |
University of Minnesota |
2021-05-01 |
| NCT03863574 |
Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03863574 |
Active, not recruiting |
Zydus Discovery DMCC |
2020-07-02 |
| NCT03861819 |
Feasibility of VIIT in Adults With NASH |
https://ClinicalTrials.gov/show/NCT03861819 |
Completed |
Duke University |
2018-12-07 |
| NCT03850886 |
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients |
https://ClinicalTrials.gov/show/NCT03850886 |
Completed |
Ain Shams University |
2019-08-07 |
| NCT03849729 |
Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery |
https://ClinicalTrials.gov/show/NCT03849729 |
Recruiting |
Hospital Juarez de Mexico |
2020-03-31 |
| NCT03844165 |
Fighting Fatty Liver in India |
https://ClinicalTrials.gov/show/NCT03844165 |
Recruiting |
University of Nottingham |
2019-07-31 |
| NCT03836937 |
Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT |
https://ClinicalTrials.gov/show/NCT03836937 |
Recruiting |
Sir Salimullah Medical College Mitford Hospital |
2020-06-30 |
| NCT03812029 |
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03812029 |
Recruiting |
Enyo Pharma |
2019-12-31 |
| NCT03811236 |
Cold-induced Brown Fat Activation and Hepatic Steatosis |
https://ClinicalTrials.gov/show/NCT03811236 |
Recruiting |
Medical University of Vienna |
2020-08-31 |
| NCT03796975 |
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03796975 |
Active, not recruiting |
Xijing Hospital |
2019-02-28 |
| NCT03791203 |
Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03791203 |
Completed |
Universiti Sains Malaysia |
2017-07-31 |
| NCT03786523 |
Time Restricted Feeding on Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03786523 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2020-08-30 |
| NCT03783195 |
Genetic-specific Effects of Fructose on Liver Lipogenesis |
https://ClinicalTrials.gov/show/NCT03783195 |
Recruiting |
University of North Carolina, Chapel Hill |
2019-12-31 |
| NCT03776175 |
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. |
https://ClinicalTrials.gov/show/NCT03776175 |
Completed |
Pfizer |
2019-09-09 |
| NCT03774511 |
Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT03774511 |
Completed |
Ahlia University |
2018-08-10 |
| NCT03763877 |
A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT03763877 |
Recruiting |
Poxel SA |
2020-02-29 |
| NCT03748628 |
Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT03748628 |
Completed |
Enanta Pharmaceuticals |
2018-10-13 |
| NCT03744182 |
A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD and in Subjects With NASH |
https://ClinicalTrials.gov/show/NCT03744182 |
Recruiting |
Hanmi Pharmaceutical Company Limited |
2019-06-20 |
| NCT03738358 |
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03738358 |
Completed |
Samsung Medical Center |
2018-03-20 |
| NCT03737071 |
The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes |
https://ClinicalTrials.gov/show/NCT03737071 |
Recruiting |
Helsinki University Central Hospital |
2019-11-30 |
| NCT03734510 |
The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study |
https://ClinicalTrials.gov/show/NCT03734510 |
Recruiting |
National Nutrition and Food Technology Institute |
2019-01-01 |
| NCT03783897 |
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects |
https://ClinicalTrials.gov/show/NCT03783897 |
Completed |
Enanta Pharmaceuticals |
2019-06-04 |
| NCT03725631 |
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD |
https://ClinicalTrials.gov/show/NCT03725631 |
Recruiting |
Korea University Guro Hospital |
2019-08-31 |
| NCT03723252 |
Dapagliflozin Efficacy and Action in NASH |
https://ClinicalTrials.gov/show/NCT03723252 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2021-11-30 |
| NCT03717935 |
Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS |
https://ClinicalTrials.gov/show/NCT03717935 |
Recruiting |
University of Colorado, Denver |
2022-09-30 |
| NCT03696797 |
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03696797 |
Recruiting |
Wake Forest University Health Sciences |
2024-02-29 |
| NCT03681457 |
Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects |
https://ClinicalTrials.gov/show/NCT03681457 |
Completed |
Novartis |
2019-09-25 |
| NCT03674476 |
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function |
https://ClinicalTrials.gov/show/NCT03674476 |
Completed |
Bristol-Myers Squibb |
2019-06-24 |
| NCT03669133 |
Vitamin E for NASH Treatment in HIV Infected Individuals |
https://ClinicalTrials.gov/show/NCT03669133 |
Recruiting |
Indiana University |
2022-12-31 |
| NCT03656744 |
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) |
https://ClinicalTrials.gov/show/NCT03656744 |
Completed |
HighTide Biopharma Pty Ltd |
2020-02-07 |
| NCT03656068 |
An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis |
https://ClinicalTrials.gov/show/NCT03656068 |
Recruiting |
Pinnacle Clinical Research, PLLC |
2019-12-31 |
| NCT03648086 |
Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03648086 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-10-31 |
| NCT03627819 |
Plant Sterols and Plant Stanols and Liver Inflammation |
https://ClinicalTrials.gov/show/NCT03627819 |
Recruiting |
Maastricht University Medical Center |
2019-10-31 |
| NCT03625362 |
Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03625362 |
Completed |
University of Novi Sad, Faculty of Sport and Physical Education |
2018-12-31 |
| NCT03614039 |
Effect of Probiotic and Smectite Gel on NAFLD |
https://ClinicalTrials.gov/show/NCT03614039 |
Completed |
Bogomolets National Medical University |
2016-03-15 |
| NCT03613480 |
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) |
https://ClinicalTrials.gov/show/NCT03613480 |
Active, not recruiting |
University Hospital of Patras |
2020-12-31 |
| NCT03610945 |
Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03610945 |
Completed |
Enanta Pharmaceuticals |
2018-08-15 |
| NCT03593343 |
Hepatic Glycogen and Fat Oxidation |
https://ClinicalTrials.gov/show/NCT03593343 |
Active, not recruiting |
Maastricht University Medical Center |
2020-09-30 |
| NCT03590626 |
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03590626 |
Completed |
Medanta, The Medicity, India |
2020-01-14 |
| NCT03587831 |
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03587831 |
Recruiting |
University of Minnesota |
2020-08-31 |
| NCT03585413 |
Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass Surgery |
https://ClinicalTrials.gov/show/NCT03585413 |
Recruiting |
Bonn Education Association for Dietetics r.A., Cologne, Germany |
2020-08-31 |
| NCT03576755 |
Spironolactone Therapy In Young Women With NASH |
https://ClinicalTrials.gov/show/NCT03576755 |
Recruiting |
University of California, San Francisco |
2022-07-31 |
| NCT03535142 |
Prognostic Significance of Fatty Liver Disease in Bariatric Patients |
https://ClinicalTrials.gov/show/NCT03535142 |
Recruiting |
Hospital of South West Jutland |
2035-06-01 |
| NCT03534141 |
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03534141 |
Recruiting |
University of California, San Francisco |
2020-06-30 |
| NCT03524365 |
Bariatric Surgery Versus Non-alcoholic Steato-hepatitis |
https://ClinicalTrials.gov/show/NCT03524365 |
Recruiting |
Catholic University of the Sacred Heart |
2021-09-30 |
| NCT03517540 |
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM) |
https://ClinicalTrials.gov/show/NCT03517540 |
Recruiting |
Novartis |
2020-08-28 |
| NCT03513588 |
2-Week Study In People With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03513588 |
Completed |
Pfizer |
2019-03-08 |
| NCT03513523 |
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03513523 |
Active, not recruiting |
Elysium Health |
2020-03-31 |
| NCT03512184 |
YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT03512184 |
Recruiting |
Weill Medical College of Cornell University |
2020-10-30 |
| NCT03508687 |
Study of Gemcabene in Adults With FPLD |
https://ClinicalTrials.gov/show/NCT03508687 |
Completed |
University of Michigan |
2019-07-31 |
| NCT03490370 |
Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH |
https://ClinicalTrials.gov/show/NCT03490370 |
Completed |
NHS Tayside |
2018-11-30 |
| NCT03486912 |
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03486912 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-09-17 |
| NCT03486899 |
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03486899 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-04-28 |
| NCT03480594 |
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway |
https://ClinicalTrials.gov/show/NCT03480594 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2020-12-31 |
| NCT03472157 |
A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients |
https://ClinicalTrials.gov/show/NCT03472157 |
Recruiting |
University Hospital, Lille |
2023-03-31 |
| NCT03467282 |
Probiotics in NASH Patients - PROBILIVER TRIAL |
https://ClinicalTrials.gov/show/NCT03467282 |
Active, not recruiting |
Hospital de Clinicas de Porto Alegre |
2020-07-31 |
| NCT03461562 |
Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT03461562 |
Completed |
Okan University |
2018-06-30 |
| NCT03459079 |
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03459079 |
Recruiting |
University of Florida |
2020-12-31 |
| NCT03449446 |
Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT03449446 |
Completed |
Gilead Sciences |
2019-11-19 |
| NCT03445208 |
A Study of Experimental Medication BMS-986036 Given to Healthy Participants |
https://ClinicalTrials.gov/show/NCT03445208 |
Completed |
Bristol-Myers Squibb |
2018-05-02 |
| NCT03444233 |
Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. |
https://ClinicalTrials.gov/show/NCT03444233 |
Completed |
University of Hohenheim |
2009-10-15 |
| NCT03439917 |
Effects of Carnitine Supplementation on Liver and Muscle |
https://ClinicalTrials.gov/show/NCT03439917 |
Recruiting |
University of Nottingham |
2020-08-30 |
| NCT03439254 |
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03439254 |
Active, not recruiting |
Intercept Pharmaceuticals |
2021-06-30 |
| NCT03436420 |
Gemcabene for the Treatment of Pediatric NAFLD |
https://ClinicalTrials.gov/show/NCT03436420 |
Completed |
Emory University |
2019-08-27 |
| NCT03434613 |
A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03434613 |
Completed |
Yonsei University |
2019-09-11 |
| NCT03426111 |
Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO). |
https://ClinicalTrials.gov/show/NCT03426111 |
Recruiting |
Puerta de Hierro University Hospital |
2020-12-31 |
| NCT01265498 |
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) |
https://ClinicalTrials.gov/show/NCT01265498 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2014-01-31 |
| NCT01264198 |
The Role of Resistance Training in Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01264198 |
Completed |
Tel-Aviv Sourasky Medical Center |
2012-09-30 |
| NCT03467217 |
Losartan for the Treatment of Pediatric NAFLD |
https://ClinicalTrials.gov/show/NCT03467217 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2020-05-31 |
| NCT01262326 |
Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose Production |
https://ClinicalTrials.gov/show/NCT01262326 |
Completed |
University of Texas Southwestern Medical Center |
2011-12-31 |
| NCT01237119 |
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01237119 |
Completed |
University of Birmingham |
2014-07-31 |
| NCT01210989 |
Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01210989 |
Completed |
Chinese University of Hong Kong |
2012-05-31 |
| NCT01208649 |
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT01208649 |
Completed |
Ruhr University of Bochum |
2010-09-30 |
| NCT01205087 |
Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT01205087 |
Completed |
Hadassah Medical Organization |
2010-12-31 |
| NCT01188083 |
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis |
https://ClinicalTrials.gov/show/NCT01188083 |
Completed |
Emory University |
2012-11-30 |
| NCT01177332 |
Elevated Circulating FFA and Intrahepatic Lipid Content |
https://ClinicalTrials.gov/show/NCT01177332 |
Completed |
Maastricht University Medical Center |
2013-06-30 |
| NCT01154985 |
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT01154985 |
Completed |
Mochida Pharmaceutical Company, Ltd. |
2012-10-31 |
| NCT01147523 |
Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01147523 |
Completed |
Aristotle University Of Thessaloniki |
2010-11-30 |
| NCT01104220 |
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk |
https://ClinicalTrials.gov/show/NCT01104220 |
Active, not recruiting |
Washington University School of Medicine |
2020-09-30 |
| NCT01094158 |
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01094158 |
Completed |
Galmed Medical Reserch |
2011-11-30 |
| NCT01084486 |
Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01084486 |
Completed |
Wolfson Medical Center |
NA |
| NCT01056133 |
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT01056133 |
Completed |
University Health Network, Toronto |
2015-01-31 |
| NCT01051219 |
Anti-Fibrotic Effects of Losartan In Nash Evaluation Study |
https://ClinicalTrials.gov/show/NCT01051219 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2014-11-30 |
| NCT01045499 |
LAGB as a Treatment for Morbid Obesity in Adolescents |
https://ClinicalTrials.gov/show/NCT01045499 |
Completed |
Columbia University |
2016-07-31 |
| NCT01038102 |
Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance |
https://ClinicalTrials.gov/show/NCT01038102 |
Completed |
Uppsala University |
2010-04-30 |
| NCT01016418 |
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01016418 |
Completed |
Hadassah Medical Organization |
2010-06-30 |
| NCT01006889 |
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT01006889 |
Completed |
University of Florida |
2009-12-31 |
| NCT01002547 |
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment |
https://ClinicalTrials.gov/show/NCT01002547 |
Completed |
VA Office of Research and Development |
2016-09-30 |
| NCT00994682 |
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) |
https://ClinicalTrials.gov/show/NCT00994682 |
Completed |
University of Florida |
2014-12-31 |
| NCT00977730 |
The Effect of Protandim on Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00977730 |
Completed |
University of Colorado, Denver |
2011-07-31 |
| NCT00968747 |
Regulation of FGF21 by Nutritional Challenges |
https://ClinicalTrials.gov/show/NCT00968747 |
Active, not recruiting |
Beth Israel Deaconess Medical Center |
2020-12-31 |
| NCT00949403 |
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00949403 |
Completed |
Washington University School of Medicine |
2011-01-31 |
| NCT00930371 |
Effect of Diet Composition on Liver Fat and Glucose Metabolism |
https://ClinicalTrials.gov/show/NCT00930371 |
Completed |
University of Washington |
2012-09-30 |
| NCT00928473 |
The Danish Childhood Obesity Biobank |
https://ClinicalTrials.gov/show/NCT00928473 |
Recruiting |
Zealand University Hospital |
2020-12-31 |
| NCT00887393 |
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates |
https://ClinicalTrials.gov/show/NCT00887393 |
Completed |
University of Michigan |
2012-09-30 |
| NCT00885313 |
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT00885313 |
Completed |
Bambino Gesù Hospital and Research Institute |
2010-04-30 |
| NCT00870012 |
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics |
https://ClinicalTrials.gov/show/NCT00870012 |
Completed |
Chinese University of Hong Kong |
2012-01-31 |
| NCT00868933 |
Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00868933 |
Completed |
Chinese University of Hong Kong |
2012-05-31 |
| NCT00856869 |
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00856869 |
Completed |
Norgine |
2005-02-28 |
| NCT00855010 |
Pioglitazone on Pancreatic Steatosis and Bone Health |
https://ClinicalTrials.gov/show/NCT00855010 |
Completed |
University of Texas Southwestern Medical Center |
2013-12-31 |
| NCT03868566 |
An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD |
https://ClinicalTrials.gov/show/NCT03868566 |
Recruiting |
Sinew Pharma Inc. |
2021-12-31 |
| NCT03617263 |
Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII) |
https://ClinicalTrials.gov/show/NCT03617263 |
Recruiting |
Zydus Discovery DMCC |
2021-04-30 |
| NCT02681055 |
Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects |
https://ClinicalTrials.gov/show/NCT02681055 |
Completed |
MediciNova |
2018-05-30 |
| NCT02581085 |
Tocotrienol Against the Progression of End Stage Liver Disease |
https://ClinicalTrials.gov/show/NCT02581085 |
Recruiting |
Indiana University |
2025-12-31 |
| NCT01399645 |
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT01399645 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2014-06-30 |
| NCT00827450 |
Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet |
https://ClinicalTrials.gov/show/NCT00827450 |
Completed |
University of Lausanne |
2010-12-31 |
| NCT04369521 |
Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04369521 |
Recruiting |
National Nutrition and Food Technology Institute |
2020-05-09 |
| NCT04198805 |
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) |
https://ClinicalTrials.gov/show/NCT04198805 |
Recruiting |
Indiana University |
2021-12-01 |
| NCT04101162 |
NAFLD Study: US vs Liver Biopsy |
https://ClinicalTrials.gov/show/NCT04101162 |
Recruiting |
University of Roma La Sapienza |
2020-10-15 |
| NCT03664596 |
Therapeutic And Dietary Effects Of The Sublimated Mare’s Milk Supplement In Patients With Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03664596 |
Active, not recruiting |
Medical Centre Hospital of the President’s Affairs Administration, Republic of Kazakhstan |
2020-09-30 |
| NCT03421431 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03421431 |
Completed |
Enanta Pharmaceuticals |
2019-06-14 |
| NCT02948647 |
Healthy Eating Through Reduction Of Excess Sugar |
https://ClinicalTrials.gov/show/NCT02948647 |
Recruiting |
University of Southern California |
2020-12-31 |
| NCT02660047 |
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent |
https://ClinicalTrials.gov/show/NCT02660047 |
Completed |
Leiden University Medical Center |
2018-03-09 |
| NCT01654549 |
Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01654549 |
Completed |
Tehran University of Medical Sciences |
2012-09-30 |
| NCT00870077 |
A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00870077 |
Completed |
University of Lausanne |
2009-12-31 |
| NCT00815009 |
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00815009 |
Completed |
San Antonio Military Medical Center |
2010-03-31 |
| NCT02009592 |
Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients |
https://ClinicalTrials.gov/show/NCT02009592 |
Completed |
Bezmialem Vakif University |
2014-01-31 |
| NCT01766713 |
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01766713 |
Completed |
University of California, San Diego |
2014-08-31 |
| NCT01634048 |
The Effect of Protein-enriched Diet on Body Composition and Appetite |
https://ClinicalTrials.gov/show/NCT01634048 |
Completed |
Imperial College London |
2015-05-31 |
| NCT01371396 |
Effect of Dietary Macronutrient Composition |
https://ClinicalTrials.gov/show/NCT01371396 |
Completed |
University of Texas Southwestern Medical Center |
2013-12-31 |
| NCT03969719 |
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT03969719 |
Recruiting |
Pfizer |
2021-02-10 |
| NCT03864783 |
The Effect of Curcumin on Liver Fat Content in Obese Subjects |
https://ClinicalTrials.gov/show/NCT03864783 |
Recruiting |
Steno Diabetes Center Copenhagen |
2020-12-31 |
| NCT03583437 |
Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD. |
https://ClinicalTrials.gov/show/NCT03583437 |
Recruiting |
University of Aarhus |
2020-09-30 |
| NCT03028740 |
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH |
https://ClinicalTrials.gov/show/NCT03028740 |
Recruiting |
Tobira Therapeutics, Inc. |
2021-10-14 |
| NCT02781584 |
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT02781584 |
Recruiting |
Gilead Sciences |
2020-11-30 |
| NCT04182646 |
Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04182646 |
Recruiting |
Asian Institute of Gastroenterology, India |
2020-09-01 |
| NCT04031729 |
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT04031729 |
Recruiting |
Massachusetts General Hospital |
2024-01-31 |
| NCT03749070 |
Effect of Silymarin in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03749070 |
Recruiting |
Hospital Universitário Professor Edgard Santos |
2021-01-04 |
| NCT03319199 |
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver |
https://ClinicalTrials.gov/show/NCT03319199 |
Completed |
HaEmek Medical Center, Israel |
2018-01-10 |
| NCT03300661 |
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine |
https://ClinicalTrials.gov/show/NCT03300661 |
Completed |
Università degli Studi di Brescia |
2019-05-17 |
| NCT03261739 |
Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT03261739 |
Completed |
Bird Rock Bio, Inc. |
2018-08-24 |
| NCT02983669 |
The Effects of Zataria Multiflora Boiss (Shirazi’s Thyme) on Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02983669 |
Completed |
Shiraz University of Medical Sciences |
2017-04-20 |
| NCT02787668 |
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity |
https://ClinicalTrials.gov/show/NCT02787668 |
Completed |
University of Alabama at Birmingham |
2018-04-30 |
| NCT02728765 |
Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02728765 |
Completed |
Chinese University of Hong Kong |
2019-03-30 |
| NCT04171765 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT04171765 |
Recruiting |
Genentech, Inc. |
2022-03-15 |
| NCT02496390 |
Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD |
https://ClinicalTrials.gov/show/NCT02496390 |
Completed |
Lawson Health Research Institute |
2018-04-30 |
| NCT02283710 |
The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02283710 |
Completed |
Tehran University of Medical Sciences |
2014-05-31 |
| NCT02157974 |
Liver and Fat Regulation in Overweight Adolescent Girls |
https://ClinicalTrials.gov/show/NCT02157974 |
Active, not recruiting |
University of Colorado, Denver |
2020-12-31 |
| NCT04210245 |
Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) |
https://ClinicalTrials.gov/show/NCT04210245 |
Recruiting |
NGM Biopharmaceuticals, Inc |
2022-06-30 |
| NCT03995056 |
Exercise Study in Subjects With NAFLD |
https://ClinicalTrials.gov/show/NCT03995056 |
Completed |
University of Eastern Finland |
2020-06-18 |
| NCT03784716 |
Ketogenic Diet in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03784716 |
Recruiting |
Cedars-Sinai Medical Center |
2022-01-31 |
| NCT00816465 |
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT00816465 |
Completed |
Hadassah Medical Organization |
2010-06-30 |
| NCT00794716 |
Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT00794716 |
Completed |
Norgine |
2010-03-31 |
| NCT00771108 |
Exercise Dose and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00771108 |
Completed |
Washington University School of Medicine |
2011-04-30 |
| NCT00760513 |
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids |
https://ClinicalTrials.gov/show/NCT00760513 |
Completed |
University Hospital Southampton NHS Foundation Trust |
2013-11-01 |
| NCT00740610 |
Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00740610 |
Completed |
Gilead Sciences |
2009-08-31 |
| NCT00730873 |
Fatty Liver and Obstructive Sleep Apnea |
https://ClinicalTrials.gov/show/NCT00730873 |
Completed |
Assaf-Harofeh Medical Center |
NA |
| NCT00714129 |
De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00714129 |
Completed |
University of California, San Francisco |
2012-10-12 |
| NCT00706537 |
Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH |
https://ClinicalTrials.gov/show/NCT00706537 |
Completed |
Pfizer |
2008-11-30 |
| NCT00681408 |
Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00681408 |
Completed |
University of Virginia |
2010-08-31 |
| NCT00680407 |
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00680407 |
Completed |
Madaus Inc |
2012-11-30 |
| NCT00668070 |
A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 |
https://ClinicalTrials.gov/show/NCT00668070 |
Completed |
Astellas Pharma Inc |
2010-10-31 |
| NCT00666016 |
Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00666016 |
Completed |
Hoffmann-La Roche |
2009-02-28 |
| NCT00655018 |
Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT00655018 |
Completed |
Bambino Gesù Hospital and Research Institute |
2006-10-31 |
| NCT00650546 |
Role of Exenatide in NASH-a Pilot Study |
https://ClinicalTrials.gov/show/NCT00650546 |
Completed |
Indiana University |
2010-08-31 |
| NCT00633282 |
Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00633282 |
Completed |
Fudan University |
2011-08-31 |
| NCT00596934 |
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00596934 |
Completed |
University of Michigan |
2009-03-31 |
| NCT00594412 |
MRI to Measure Liver Fat Content |
https://ClinicalTrials.gov/show/NCT00594412 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-07-01 |
| NCT00590161 |
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00590161 |
Completed |
Case Western Reserve University |
2010-07-31 |
| NCT00586911 |
Betaine in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00586911 |
Completed |
Mayo Clinic |
2006-06-30 |
| NCT00586885 |
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00586885 |
Completed |
Mayo Clinic |
2006-06-30 |
| NCT00586313 |
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) |
https://ClinicalTrials.gov/show/NCT00586313 |
Completed |
Indiana University |
2008-07-31 |
| NCT00585299 |
Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD |
https://ClinicalTrials.gov/show/NCT00585299 |
Completed |
Yale University |
2010-06-30 |
| NCT00509418 |
Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00509418 |
Completed |
Catalysis SL |
2007-09-30 |
| NCT00501592 |
Study of INT-747 in Patients With Diabetes and Presumed NAFLD |
https://ClinicalTrials.gov/show/NCT00501592 |
Completed |
Intercept Pharmaceuticals |
2009-02-28 |
| NCT00492700 |
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00492700 |
Completed |
Association pour la Recherche sur les Maladies Hépatiques Virales |
NA |
| NCT00480922 |
Effects of a Low Glycemic Load Diet on Fatty Liver in Children |
https://ClinicalTrials.gov/show/NCT00480922 |
Completed |
Boston Children’s Hospital |
2009-12-31 |
| NCT00476879 |
Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content |
https://ClinicalTrials.gov/show/NCT00476879 |
Completed |
University of Aarhus |
2007-11-30 |
| NCT00470171 |
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00470171 |
Completed |
Axcan Pharma |
2008-11-30 |
| NCT00457938 |
Novel Therapies for Metabolic Complications of Lipodystrophies |
https://ClinicalTrials.gov/show/NCT00457938 |
Completed |
University of Texas Southwestern Medical Center |
2014-11-30 |
| NCT00457639 |
Cholic Acid for Hepatic Steatosis in Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00457639 |
Completed |
University of Texas Southwestern Medical Center |
2011-04-30 |
| NCT00820651 |
Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00820651 |
Completed |
Catalysis SL |
2012-04-30 |
| NCT00443079 |
A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00443079 |
Completed |
University of California, San Diego |
2009-12-31 |
| NCT00441272 |
Pioglitazone to Treat Fatty Liver in People With HIV Infection |
https://ClinicalTrials.gov/show/NCT00441272 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-10-31 |
| NCT00799578 |
A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00799578 |
Completed |
University of California, San Diego |
2009-06-30 |
| NCT00401336 |
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging |
https://ClinicalTrials.gov/show/NCT00401336 |
Completed |
Rennes University Hospital |
2013-03-31 |
| NCT00389376 |
Phase I Trial of Silymarin for Chronic Liver Diseases |
https://ClinicalTrials.gov/show/NCT00389376 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
2008-01-31 |
| NCT00323414 |
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver |
https://ClinicalTrials.gov/show/NCT00323414 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2011-12-31 |
| NCT00267670 |
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH |
https://ClinicalTrials.gov/show/NCT00267670 |
Completed |
Northwestern University |
2009-09-30 |
| NCT00266019 |
Weight Management in Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00266019 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00262964 |
Obesity and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00262964 |
Completed |
Washington University School of Medicine |
2008-12-31 |
| NCT00244569 |
Development of a Breath Test for Monitoring Patients With Liver Disease |
https://ClinicalTrials.gov/show/NCT00244569 |
Completed |
Virginia Commonwealth University |
2007-04-30 |
| NCT00230113 |
Effect of Omega-3 PUFA Supplementation in NAFLD Patients |
https://ClinicalTrials.gov/show/NCT00230113 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2010-06-30 |
| NCT00230087 |
Iron Depletion Therapy for Type 2 DM and NAFLD |
https://ClinicalTrials.gov/show/NCT00230087 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2010-06-30 |
| NCT00229255 |
Relation of Obesity With Frequency of Meals (MST 0557) |
https://ClinicalTrials.gov/show/NCT00229255 |
Completed |
Rockefeller University |
2009-06-30 |
| NCT00227110 |
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00227110 |
Completed |
The University of Texas Health Science Center at San Antonio |
2005-11-30 |
| NCT00207311 |
Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus |
https://ClinicalTrials.gov/show/NCT00207311 |
Completed |
Brooke Army Medical Center |
2009-05-31 |
| NCT00160407 |
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) |
https://ClinicalTrials.gov/show/NCT00160407 |
Completed |
St. Louis University |
NA |
| NCT00108589 |
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT00108589 |
Completed |
VA Office of Research and Development |
NA |
| NCT00819338 |
The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00819338 |
Completed |
University of Nottingham |
2010-03-31 |
| NCT00063635 |
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) |
https://ClinicalTrials.gov/show/NCT00063635 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2009-09-30 |
| NCT00063622 |
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) |
https://ClinicalTrials.gov/show/NCT00063622 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2009-06-30 |
| NCT00063232 |
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin |
https://ClinicalTrials.gov/show/NCT00063232 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-03-31 |
| NCT00062764 |
Treating Nonalcoholic Steatohepatitis With Pioglitazone |
https://ClinicalTrials.gov/show/NCT00062764 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-02-28 |
| NCT00641524 |
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT00641524 |
Completed |
University of Western Ontario, Canada |
2011-12-31 |
| NCT00013598 |
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone |
https://ClinicalTrials.gov/show/NCT00013598 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004697 |
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition |
https://ClinicalTrials.gov/show/NCT00004697 |
Completed |
FDA Office of Orphan Products Development |
NA |